drugset / Trial / NCT00697567
Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of the phase IIa study in healthy HSV seropositive and HSV seronegative adults is to evaluate the immunogenicity, reactogenicity and safety of herpes simplex (gD) candidate vaccine with or without adjuvant administered according to a 0, 1, 6 month schedule.
Timeline
- Start
- 1992-09
- Primary completion
- 1997-12
- Completion
- 1997-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK208141 | Vaccine | — | Intramuscular |
Indications
No indication recorded.